Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland.

IF 2.1 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Swiss medical weekly Pub Date : 2024-10-03 DOI:10.57187/s.3958

Maria Trottmann, Eva Blozik, Marcel Hilbig, Mark Pletscher, Niklaus Meier

引用次数: 0

Abstract

No abstract available.

查看原文本刊更多论文

回复 Arber C 等人关于 "瑞士大 B 细胞淋巴瘤 CAR-T 治疗后的实际支出和存活时间 "的评论：瑞士大 B 细胞淋巴瘤 CAR-T 治疗后的实际支出和存活时间。

无摘要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Swiss medical weekly 医学-医学：内科

CiteScore

5.00

自引率

0.00%

发文量

审稿时长

3-8 weeks

期刊介绍： The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics.